Author Archives: Charlotte Buchanan, Candidate for MBA, Class of 2015

Week in DC: Additional insight into pharma/biotech industries

Our guest speaker from Breakaway Policy Strategies provided additional insight into the pharma/biotech industries and how drug costs, marketing efforts, and FDA activities are impacting the bio-pharma/med device landscape.  Some areas of interest included: Although prescription drug costs get a …

Week in DC: Controlling the cost of healthcare

Loren Adler, a Research Director from the bipartisan Committee for a Responsible Federal Budget, discussed one of the week’s recurring themes, talking about the rising proportion of US GDP consumed by healthcare spend over the past 4 decades (currently 20%) …

Week in DC: The role of hospice and palliative care

Health care cost in the US is increasing in overwhelming pace, aging population being the major factor. The population over the age of 65 is already over 12% and is reaching 15% by 2015. In fact, the fastest growing demographic …

Week in DC: Exposure to all aspects of healthcare policy

The “Week in DC” exposes students to all aspects of healthcare policy, governmental as well as corporate influences and the general power structure that influences the execution of medical care in the United States. For those who have been practicing …

Week in DC: A great way to hear about healthcare reform

I was delighted to have the chance to hear from the Vice President of Policy and Regulatory Affairs for America’s Health Insurance Plans (AHIP) speak during my Week In DC trip as part of Fuqua’s Health Policy Class.  I am …

Week in DC: One of the best memories I have at Fuqua

Simultaneously, one of the best and worst aspects of being a student of health care is how immense and complex the sector is. When my classmates and I first took a glance at the “Week in DC” agenda – packed …

Week in Cities Europe: A great learning experience

The inaugural Week in Cities – Europe was a great success. We met with a variety of different companies in both England and Switzerland, learning about their products, strategies and the general international healthcare trends each of these companies are …